June 21, 2017
Drugmaker Mylan gets boost from unlikely source: coal
Mylan N.V. <MYL.O> is best known for producing EpiPen emergency allergy treatments and generic drugs.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: EpiPen
May 31, 2017
Mylan may have overcharged U.S. for EpiPen by $1.27 billion: HHS
The U.S. government may have overpaid drugmaker Mylan N.V. by as much as $1.27 billion between 2006 and 2016 for its EpiPen emergency allergy treatment, the Department of Health and Human Services said on Wednesday.
March 31, 2017
Pharmacy chain works to help curb opioid epidemic
The drugstore chain Walgreens is taking a three-pronged approach to combat the public health crisis stemming from prescription opioids, according to a team of pharmacists and other clinicians from the company.
March 28, 2017
Mylan underpayment on EpiPen could exceed proposed settlement -study
The amount that drugmaker Mylan NV avoided paying the U.S. government in Medicaid rebates for its EpiPen emergency allergy treatment since 2007 likely exceeds a proposed $465 million settlement the company announced in October, according to a study by private drug pricing experts published on Monday.
October 31, 2016
Exclusive: EpiPen price hikes add millions to Pentagon costs
Mylan NV’s price hikes on EpiPens have added millions to U.S. Department of Defense spending…